Associated Papers
Effects of ABCG2 421C > A genetic polymorphism on the pharmacokinetics of rivaroxaban in healthy Chinese subjects.
Guo L et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems, 2025
Effect of donor GSTM3 rs7483 genetic variant on tacrolimus elimination in the early period after liver transplantation.
Zhang T et al.
Peerj, 2024
39465171 (PubMed )
Supplement: peerj-12-18360-s002.7z › drug-metabolizing_enzymes_and_transporter__DMET__microarray › markerlist.xlsx › markerlist.TXT
Genetic Heterogeneity of SLC22 Family of Transporters in Drug Disposition.
Lozano E et al.
Journal of Personalized Medicine, 2018
Pharmacogenomics of Methotrexate Membrane Transport Pathway: Can Clinical Response to Methotrexate in Rheumatoid Arthritis Be Predicted?
Lima A et al.
International Journal of Molecular Sciences, 2015
26086825 (PubMed )
Supplement: ijms-16-13760-s001.pdf
Genome-wide analysis to predict protein sequence variations that change phosphorylation sites or their corresponding kinases.
Ryu GM et al.
Nucleic Acids Research, 2009
19139070 (PubMed )
Supplement: gkn1008_nar-01723-s-2008-File009.xls › TypeI_
Molecular insights into the structure-function relationship of organic anion transporters OATs.
Zhou F et al.
Pharmaceutical Research, 2007
The human organic anion transporter 3 (OAT3; SLC22A8): genetic variation and functional genomics.
Erdman AR et al.
American Journal of Physiology. Renal Physiology, 2006
Select a paper to view details